[Clinical experience with the treatment of gingival hyperplasia induced by calcium channel blocking agents] - PubMed (original) (raw)
Review
. 1999 Dec;92(12):363-72.
[Article in Hungarian]
Affiliations
- PMID: 10641419
Review
[Clinical experience with the treatment of gingival hyperplasia induced by calcium channel blocking agents]
[Article in Hungarian]
T Keglevich et al. Fogorv Sz. 1999 Dec.
Abstract
The prevalence of the nifedipine-induced gingival hyperplasia is ranging from 0.5-83% in the dental literature. The pathomechanism of the nifedipine-induced gingival hyperplasia is not clearly understood. Evaluating the dental history and the course of disease of 34 patients treated and followed up at the Department of Periodontology the following answers were raised: What sort of local and systemic factors are enhancing the recurrence of the gingival overgrowth and how this can be anticipated in patients on continuous Ca channel blocking medication. Eight out of the 34 patients participating in the clinical trial did not remember the onset of their gingival overgrowth. 10 cases developed three years and three cases after less then one year of the onset of the drug administrations. 27 out of the 34 cases required gingival surgery and seven showed good clinical improvement after the hygienic phase of the comprehensive periodontal treatment. 70% of the gingival hyperplasia cases presented no clinical sign of recurrence one year after the completion of the active phase of the treatment. A positive correlation was found between the oral hygiene and the recurrence rate of gingival overgrowth. Oral hygiene seems to play a decisive role in the development of gingival enlargement. The present findings and substantial evidences from the dental literature indicate that the gingival enlargement can be successfully controlled even under the continuous nifedipine administration by meticulous professional and individual oral hygiene.
Similar articles
- [Organ transplant patients' complex periodontal treatment].
Keglevich T, Benedek E, Gera I. Keglevich T, et al. Fogorv Sz. 2005 Oct;98(5):199-204. Fogorv Sz. 2005. PMID: 16315856 Hungarian. - [Gingival hyperplasia during treatment with nifedipine].
Bokor-Bratić M, Vucković N, Selaković S. Bokor-Bratić M, et al. Med Pregl. 1998 Sep-Oct;51(9-10):445-8. Med Pregl. 1998. PMID: 9863337 Croatian. - Prevention and treatment considerations in patients with drug-induced gingival enlargement.
Hall EE. Hall EE. Curr Opin Periodontol. 1997;4:59-63. Curr Opin Periodontol. 1997. PMID: 9655022 Review. - Nifedipine-induced gingival enlargement around dental implants: a clinical report.
Silverstein LH, Koch JP, Lefkove MD, Garnick JJ, Singh B, Steflik DE. Silverstein LH, et al. J Oral Implantol. 1995;21(2):116-20. J Oral Implantol. 1995. PMID: 8699502 - Nifedipine-induced gingival overgrowth: remission following non-surgical therapy.
Ciantar M. Ciantar M. Dent Update. 1996 Nov;23(9):374-7. Dent Update. 1996. PMID: 9452616 Review.